Tatiana Gogoleva
About Tatiana Gogoleva
Tatiana Gogoleva is the Director of Clinical Operations at Sangamo Therapeutics, Inc., where she has worked since 2017. She has a background in biology and chemistry, holding an MS from Saint Petersburg State University, and has held various roles in clinical operations and research across several pharmaceutical companies.
Current Role at Sangamo Therapeutics
Tatiana Gogoleva serves as the Director of Clinical Operations at Sangamo Therapeutics, Inc. since 2017. In this role, she oversees the clinical operations team and is responsible for the planning and execution of clinical trials. Her work is crucial in advancing the company's gene therapy and genomic medicine initiatives. Based in the San Francisco Bay Area, she contributes to the strategic direction of clinical programs.
Previous Experience in Clinical Research
Tatiana Gogoleva has extensive experience in clinical research prior to her current position. She worked at Anacor Pharmaceuticals as a Clinical Trial Manager from 2010 to 2013, where she managed various clinical trials. Before that, she served as a Senior Clinical Research Associate at Cubist Pharmaceuticals for one year, from 2009 to 2010. Additionally, she worked at ICON Clinical Research as a Clinical Research Associate from 2002 to 2005 and at XOMA as Associate Scientist III from 1999 to 2002.
Educational Background
Tatiana Gogoleva studied at Saint Petersburg State University, where she focused on Biology and Chemistry. She obtained teaching credentials and achieved a Master of Science degree. Her educational background provides a solid foundation for her career in clinical operations and research.
Career Progression in Pharmaceuticals
Tatiana Gogoleva's career in the pharmaceutical industry spans over two decades. She began her career as an Associate Scientist III at XOMA and progressed to various roles in clinical research. Her roles have included Clinical Research Associate positions and management roles, culminating in her current position as Director of Clinical Operations at Sangamo Therapeutics.